Company Quick10K Filing
Galera Therapeutics
10-Q 2021-03-31 Filed 2021-05-11
10-K 2020-12-31 Filed 2021-03-11
10-Q 2020-09-30 Filed 2020-11-10
10-Q 2020-06-30 Filed 2020-08-10
10-Q 2020-03-31 Filed 2020-05-12
10-K 2019-12-31 Filed 2020-03-10
S-1 2019-10-11 Public Filing
10-Q 2019-09-30 Filed 2019-12-10
8-K 2021-01-06
8-K 2020-11-10
8-K 2020-09-24
8-K 2020-09-16
8-K 2020-09-09
8-K 2020-08-10
8-K 2020-07-14
8-K 2020-06-09
8-K 2020-05-12
8-K 2020-05-11
8-K 2020-03-31
8-K 2020-03-10
8-K 2019-12-10
8-K 2019-11-12

Galera Therapeutics Financials

GRTX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2019-09-30
Cash15,719
Accounts Receivable
Inventory
PP&E1,333
Assets79,758
Accounts Payable5,218
Long-Term Debt
Liabilities52,298
Stockholders' Equity-144,620
Income Statement ($'000)2019-09-30
Revenue
Cost of Revenue
Gross Profit
R&D11,040
SG&A1,816
Tax
Net Income-13,351
Cash Flow ($'000)2019-09-30
Cash Operating
Cash Investing
Cash Financing